FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic - CNBC

* FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic  CNBC
* FTC Targets 'Junk' Patent Listings on Ozempic and Other Drugs  The Wall Street Journal
* US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition  ABC News
* FTC challenges 'bogus' patents on Ozempic, other drugs that 'block competition'  MarketWatch
* FTC Warns 'Junk Patents' Could Make Drugs Like Ozempic Pricier—Here's How  Forbes


http://dlvr.it/T6Dr9R